| Ito Y, Kobayashi K
[Chemotherapy for breast cancer refractory to anthracycline, taxane or trastuzumab.] [English Abstract, Journal Article]
Gan To Kagaku Ryoho 2009 May; 36(5):726-9.
Abstract | Full Citation | Find Related Articles |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Mar; 31(2):107-46.
Abstract | Full Citation |
| Dizon DS, Blessing JA, McMeekin DS, et al.
Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P. [JOURNAL ARTICLE]
J Clin Oncol 2009 May 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Yardley DA
Proactive Management of Adverse Events Maintains the Clinical Benefit of Ixabepilone. [JOURNAL ARTICLE]
Oncologist 2009 May 1.
Abstract | Full Citation |
| Kurebayashi J
Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics. [JOURNAL ARTICLE]
Breast Cancer 2009 May 1.
Abstract | Full Citation | Find Related Articles |
| Morris PG, Fornier MN
Ixabepilone and Other Epothilones: Microtubule-targeting Agents for Metastatic Breast Cancer. [Journal Article]
Clin Adv Hematol Oncol 2009 Feb; 7(2):115-22.
Abstract | Full Citation | Find Related Articles |
| Rosenberg JE, Ryan CJ, Weinberg VK, et al.
Phase I Study of Ixabepilone, Mitoxantrone, and Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy: A Study of the Department of Defense Prostate Cancer Clinical Trials Consortium. [JOURNAL ARTICLE]
J Clin Oncol 2009 Apr 6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Reed SD, Li Y, Anstrom KJ, et al.
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Oncol 2009 May 1; 27(13):2185-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Hillner BE, Smith TJ
Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing. [Comment, Editorial]
J Clin Oncol 2009 May 1; 27(13):2111-3.
Full Citation | Publisher Full Text | Find Related Articles |
| Villanueva C, Vuillemin AT, Demarchi M, et al.
Ixabepilone: a new active chemotherapy in the treatment of breast cancer. [JOURNAL ARTICLE]
Womens Health (Lond Engl) 2009 Mar; 5(2):115-121.
Abstract | Full Citation |
  |
